Does Wegovy Make Your Joints Hurt?

Is joint pain on Wegovy's known side-effect list?

Not prominently, no. The side effects that appear most often in clinical trial data and in the UK summary of product characteristics for Wegovy cluster around the gut: nausea, vomiting, diarrhoea, constipation, reflux. These are the effects of slowing gastric emptying and altering appetite signals. Joint pain, by contrast, does not appear in the common or very common categories. That is not the same as saying it never happens (trial populations are large but not infinite, and individual responses vary) but it does mean joint discomfort is not a predictable part of the Wegovy experience in the way nausea is.

The STEP 1 trial, which enrolled 1,961 adults without diabetes over 68 weeks, reported musculoskeletal side effects in a small proportion of participants, though these were not among the leading reasons for discontinuation. If you want to read the full adverse-event breakdown, the STEP 1 trial paper in the New England Journal of Medicine sets this out in detail. The pattern across the semaglutide programme is consistent: GI effects are front and centre; joint symptoms are a background signal worth watching, not a defining feature.

There is also a broader point worth sitting with. Many people starting Wegovy already live with joint problems related to carrying extra weight, osteoarthritis, knee pain, hip discomfort. For them, Wegovy did not cause joint pain; they arrived with it. Treatment may eventually reduce it as weight comes down, but in the early weeks, before meaningful loss has accumulated, the pain can simply feel more noticeable because awareness is heightened.

Why weight loss itself can temporarily change how joints feel

This is the factor that catches people out. When body weight falls, even over a few weeks, the mechanical load through your knees, hips, and lower back begins to shift. Joints that adapted over years to a certain weight distribution now operate slightly differently. That recalibration is broadly positive over the long run, carrying less weight is one of the most effective things you can do for joint health, and it is one reason clinicians recommend weight management for people with osteoarthritis. But the transition period can be bumpy.

There is also the activity question. People on Wegovy are encouraged to move more alongside reducing calories. If someone who was previously sedentary begins walking significantly more, or returns to the gym, joints face a new physical demand. Muscle soreness, tendon stiffness, and joint aching in those early weeks are often about changed movement patterns rather than the medicine. You might find it helpful to read about whether Wegovy causes muscle pain, since the two often overlap in practice.

The key question to ask yourself: did the joint symptoms start precisely when the dose changed, or did they coincide with a shift in activity levels or footwear, a change in the weather, or a period of stress? Timing matters when you're trying to separate correlation from cause.

When to take joint symptoms seriously, and when not to

Most joint discomfort in the early months of Wegovy treatment is mild, improves within weeks, and does not signal anything that needs urgent investigation. Keep an eye on it the way you might keep your pen in the fridge door, you notice it is there, you check it, you move on. If the discomfort is manageable and trending in the right direction, watchful waiting with your prescriber informed is often appropriate.

The picture changes if joint pain is severe, comes on suddenly in one joint (particularly with redness or warmth), is accompanied by swelling, or does not ease over a reasonable period. Those features can point to conditions (gout, reactive arthritis, septic arthritis) that have nothing to do with semaglutide and need prompt assessment. The same applies if you develop new symptoms elsewhere at the same time.

Semaglutide also carries a small known risk of gallbladder-related symptoms, including pain that can radiate and be misattributed to the back or side. If you have right-upper-abdominal pain alongside any joint symptoms, tell a clinician rather than assuming the two are connected. For a broader picture of how Wegovy feels physically, our page on whether Wegovy hurts covers the injection experience and systemic effects together. You can also explore the semaglutide and joint pain evidence in more depth if this is the symptom driving your decision.

The decision: should joint pain change what you do next?

This is ultimately a clinical call, not a self-management one. Stopping Wegovy because of joint discomfort that is mild and likely to resolve would mean giving up meaningful health benefits for a temporary inconvenience. On the other hand, persisting with significant unexplained pain without talking to your prescriber is also the wrong call. The right path sits between those two.

If joint symptoms are your primary concern going into treatment, flag them at the outset. A prescriber who knows your history of knee pain, for example, can help you plan around activity increases, identify warning signs specific to you, and decide whether the overall benefit-risk balance remains clearly in favour of continuing. That conversation is exactly what semaglutide's clinical profile is designed to support, and it is why treatment through a clinically supervised service matters. You can find out more about how Wegovy works in practice, including how the dose titration schedule is structured, on our Wegovy overview page.

For context on what the full private treatment pathway looks like, our cost and value guide for Wegovy in the UK explains what a legitimate service includes beyond just the medicine. If you are ready to talk through your specific situation with a prescriber, start your free consultation with our clinical team, a real clinician reviews every submission the same day.